Tris Pharma Announces US District Court Upholds Validity of QuilliChew ER® Patents; Rules Teva Infringes Tris Patents
MONMOUTH JUNCTION, N.J., Aug. 18, 2022 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) a fully integrated pharmaceutical company with a robust portfolio…